
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf Inc. has demonstrated robust growth, with order entry for 2025 increasing approximately 17% year-over-year, driven by strong demand in both the banking and retail segments. The banking product revenues surged to $381 million, reflecting a 20% year-over-year increase, while total banking revenues reached $798 million, representing an 11% rise year-over-year and a notable 16% quarter-over-quarter growth. Furthermore, the company has achieved consistent positive free cash flow, with $196 million generated in the fourth quarter, indicating a solid financial foundation and a strong outlook for sustained growth into 2026 and 2027.
Bears say
Diebold Nixdorf Inc. faces a challenging outlook as the company's backlog is projected to decline sequentially, indicating potential difficulties in maintaining revenue momentum in the upcoming quarter. Additionally, operational constraints, such as tariff-related costs and supply chain disruptions, may hinder the company's ability to realize expected efficiencies and revenue growth, while a lack of consistent upgrade and replacement activity in the banking vertical raises concerns about future order trends. Despite targeting significant free cash flow generation from 2025 to 2027, the current market conditions and inherent liquidity risks suggest that the company's financial stability may remain under pressure.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares